Fospropofol

Fospropofol
	Chemical structure of fospropofol disodium
Clinical data
AHFS/Drugs.com	Monograph
License data	US FDA: Fospropofol;
Pregnancy; category	B;
Dependence; liability	unknown
Routes of; administration	Intravenous
ATC code	N01 ;
Legal status
Legal status	US: Schedule IV;
Pharmacokinetic data
Protein binding	98%
Metabolism	Hepatic glucuronidation
Elimination half-life	0.81 hours
Excretion	Renal
Identifiers
	IUPAC name disodium [2,6-di(propan-2-yl)phenoxy]methyl phosphate;
CAS Number	258516-89-1 ; Disodium salt: 258516-87-9;
PubChem CID	3038498; Disodium salt: 3038497;
DrugBank	DB06716 ; Disodium salt: DBSALT000090;
ChemSpider	2302062 ; Disodium salt: 2302061;
UNII	LZ257RZP7K; Disodium salt: 30868AY0IF;
KEGG	Disodium salt: D04257;
ChEMBL	ChEMBL1201766 ;
CompTox Dashboard (EPA)	DTXSID50870295 ;
Chemical and physical data
Formula	C13H21O5P
Molar mass	288.280 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES CC(C)c1cccc(c1OCOP(=O)(O)O)C(C)C;
	InChI InChI=1S/C13H21O5P/c1-9(2)11-6-5-7-12(10(3)4)13(11)17-8-18-19(14,15)16/h5-7,9-10H,8H2,1-4H3,(H2,14,15,16) ; Key:QVNNONOFASOXQV-UHFFFAOYSA-N ;
	(what is this?) (verify)

Fospropofol (INN), often used as the disodium salt (trade name Lusedra), is an intravenous sedative-hypnotic agent. It is currently approved for use in sedation of adult patients undergoing diagnostic or therapeutic procedures such as endoscopy.